Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.97
-0.13 (-1.83%)
Apr 29, 2026, 12:10 PM EDT - Market open
Precision BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 110.82 | 85.9 | 116.68 | 189.58 | 143.66 | Upgrade
|
| Short-Term Investments | 4.76 | 0.41 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 115.59 | 86.31 | 116.68 | 189.58 | 143.66 | Upgrade
|
| Cash Growth | 33.91% | -26.02% | -38.45% | 31.96% | 59.98% | Upgrade
|
| Accounts Receivable | - | 1.7 | 0.9 | 0.72 | 0.49 | Upgrade
|
| Receivables | - | 1.7 | 12.8 | 0.72 | 0.49 | Upgrade
|
| Prepaid Expenses | 3.11 | 6.44 | 5.98 | 6.03 | 17.43 | Upgrade
|
| Other Current Assets | 0.05 | 0.54 | 0.91 | 2.78 | 0.17 | Upgrade
|
| Total Current Assets | 118.74 | 94.99 | 136.36 | 199.11 | 161.75 | Upgrade
|
| Property, Plant & Equipment | 7.23 | 10.18 | 14.6 | 13.78 | 29.33 | Upgrade
|
| Long-Term Investments | 0.74 | 3.21 | 3.21 | 4.75 | 6.84 | Upgrade
|
| Other Intangible Assets | 1.17 | 0.62 | 0.4 | 0.73 | 2.05 | Upgrade
|
| Other Long-Term Assets | 26.54 | 22.79 | 0.23 | 12.57 | 4.64 | Upgrade
|
| Total Assets | 154.42 | 136.39 | 159.78 | 238.17 | 211.5 | Upgrade
|
| Accounts Payable | 0.3 | 1.31 | 2.97 | 0.65 | 1.14 | Upgrade
|
| Accrued Expenses | 6.46 | 7.2 | 6.54 | 6.93 | 10.79 | Upgrade
|
| Short-Term Debt | - | - | 22.41 | - | - | Upgrade
|
| Current Portion of Leases | 1.51 | 1.32 | 1.13 | 1.68 | 1.82 | Upgrade
|
| Current Unearned Revenue | - | 2.96 | 12.04 | 46.19 | 21.24 | Upgrade
|
| Other Current Liabilities | 0.65 | 2.19 | 4.9 | 4.21 | 0.98 | Upgrade
|
| Total Current Liabilities | 8.91 | 14.98 | 49.99 | 59.66 | 35.98 | Upgrade
|
| Long-Term Debt | 22.4 | 22.32 | - | 22.22 | 2.48 | Upgrade
|
| Long-Term Leases | 4.9 | 6.4 | 7.72 | 1.06 | 4.81 | Upgrade
|
| Long-Term Unearned Revenue | 10 | 33.3 | 83.08 | 92.87 | 77.02 | Upgrade
|
| Other Long-Term Liabilities | 15.95 | 2.99 | 0.13 | 1.92 | 0.04 | Upgrade
|
| Total Liabilities | 62.17 | 80 | 140.92 | 177.74 | 120.33 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 621.39 | 539.81 | 509.44 | 489.7 | 408.8 | Upgrade
|
| Retained Earnings | -528.19 | -482.46 | -489.63 | -428.31 | -316.68 | Upgrade
|
| Treasury Stock | -0.95 | -0.95 | -0.95 | -0.95 | -0.95 | Upgrade
|
| Total Common Equity | 92.25 | 56.39 | 18.86 | 60.43 | 91.17 | Upgrade
|
| Shareholders' Equity | 92.25 | 56.39 | 18.86 | 60.43 | 91.17 | Upgrade
|
| Total Liabilities & Equity | 154.42 | 136.39 | 159.78 | 238.17 | 211.5 | Upgrade
|
| Total Debt | 28.81 | 30.05 | 31.27 | 24.96 | 9.11 | Upgrade
|
| Net Cash (Debt) | 86.78 | 56.27 | 85.41 | 164.62 | 134.55 | Upgrade
|
| Net Cash Growth | 54.22% | -34.12% | -48.12% | 22.35% | 69.72% | Upgrade
|
| Net Cash Per Share | 6.77 | 8.17 | 22.23 | 56.19 | 68.78 | Upgrade
|
| Filing Date Shares Outstanding | 24.73 | 10.48 | 6.92 | 3.71 | 2.03 | Upgrade
|
| Total Common Shares Outstanding | 24.09 | 8.2 | 4.16 | 3.7 | 2.03 | Upgrade
|
| Working Capital | 109.83 | 80.01 | 86.37 | 139.44 | 125.77 | Upgrade
|
| Book Value Per Share | 3.83 | 6.87 | 4.53 | 16.34 | 44.91 | Upgrade
|
| Tangible Book Value | 91.08 | 55.77 | 18.46 | 59.7 | 89.12 | Upgrade
|
| Tangible Book Value Per Share | 3.78 | 6.80 | 4.43 | 16.14 | 43.90 | Upgrade
|
| Machinery | 17.62 | 18.7 | 19.38 | 20.78 | 22.93 | Upgrade
|
| Construction In Progress | - | 0.01 | 0.07 | 0.52 | 3.04 | Upgrade
|
| Leasehold Improvements | 12.06 | 12.03 | 11.95 | 11.95 | 22.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.